Verrica reports positive Phase III results of VP-102 in molluscum
VP-102 is a topical solution being developed to treat highly infectious molluscum contagiosum. Credit: Olga Kononenko on Unsplash.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
-
Pilloxa
Pilloxa creates digital and remote solutions to optimise clinical trials...
About
Pilloxa creates digital and remote solutions to optimise clinical trials and patient support programmes through supporting medical adherence and patient retention.
FollowMake an Enquiry
-
SynapCon
SynapCon specialises in the development of innovative software solutions for...
About
SynapCon specialises in the development of innovative software solutions for clinical trial and medical research project management.
FollowMake an Enquiry
-
CSM, a Clinigen company
CSM, a Clinigen company, focuses on clinical trial supplies and...
About
CSM, a Clinigen company, focuses on clinical trial supplies and biological sample management services.
FollowMake an Enquiry